Willis Investment Counsel Maxcyte, Inc. Transaction History
Willis Investment Counsel
- $1.45 Billion
- Q1 2025
A detailed history of Willis Investment Counsel transactions in Maxcyte, Inc. stock. As of the latest transaction made, Willis Investment Counsel holds 380,471 shares of MXCT stock, worth $977,810. This represents 0.07% of its overall portfolio holdings.
Number of Shares
380,471
Previous 405,471
6.17%
Holding current value
$977,810
Previous $1.69 Million
38.43%
% of portfolio
0.07%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.7MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$24 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$20.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$14 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$13 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$11.3 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $261M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...